Skip to main content
ConductScienceScienceDex

Barton F. Haynes

NIH Rank #48
Unclaimed recordClaim profile
  • Top 1% Funded
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1858798Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2025 award categories

  • Internal Medicine

NIH Funding · FY2024

Linked Award Amount
$36.9M
Full award amounts, FY2024
Award Records
7
Records listing this PI
Award-Linked Rank
#48
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Barton F. Haynes. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Barton F. Haynes as a PI. Multi-PI records show the full award amount for context.

  • 5UM1AI144371-06UM1
    Induction of protective antibodies for HIV vaccine development
    Duke University
    $21M
    award amount
  • 3UM1AI144371-06S5UM1
    Manufacture a protein encoding CAP256.wk34.c80 OPT4 envelope for induction of V2 Apex bnAbs
    Duke University
    $5.3M
    award amount
  • 3UM1AI144371-06S4UM1
    Manufacture an mRNA/LNP encoding an HIV envelope designed to bind and stimulate multiple V2 Apex broadly neutralizing antibody B cell lineages
    Duke University
    $3.2M
    award amount
  • 3UM1AI144371-06S1UM1
    Nonhuman primate studies for development of a prototype HIV vaccine that induces broadly neutralizing antibodies
    Duke University
    $3.2M
    award amount
  • 3UM1AI144371-06S3UM1
    Immunologic evaluation of HIV-1 HVTN experimental medicine trials HVTN 307, HVTN 309 and HVTN312
    Duke University
    $2.7M
    award amount
  • 3UM1AI144371-06S2UM1
    HIV-1 Env immunogens that target unmutated common ancestor antibodies (UCAs) of broadly neutralizing antibodies (bnAbs) reactive with multiple HIV-1 envelope epitopes
    Duke University
    $809.7K
    award amount
  • 5U19AI142596-05U19
    Messenger RNA Immunogens for initiation of protective HIV non-neutralizing antibodies
    Duke University
    $677.6K
    award amount

Award organization

Organizations that administered FY2024 awards listing Barton F. Haynes as a PI.

FY2024 award administered by Duke University (NC).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Duke University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    $10M Cumulative Funding
  7. 2024
    $25M Cumulative Funding
  8. 2024
    Entered Top 50% Nationally
    Ranked #48
  9. 2024
    Entered Top 25% Nationally
    Ranked #48
  10. 2024
    Entered Top 10% Nationally
    Ranked #48
  11. 2024
    Entered Top 5% Nationally
    Ranked #48
  12. 2024
    Entered Top 1% Nationally
    Ranked #48
  13. 2025
    $50M Cumulative Funding

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Barton F. Haynes.

Thomas Denny
Duke University
1
shared award

Explore further

Find collaborators for Barton F. Haynes

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →